Liquid nitrogen-treated autografts for bone and soft tissue tumors

Liquid nitrogen-treated autografts for bone and soft tissue tumors - Liquid nitrogen-treated autografts

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018802

Enrollment

Registered

2015-08-25

Start date

2015-08-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary bone and soft tissue tumor Metastatic bone tumor

Interventions

Liquid nitrogen-treated autograft

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The case judged that reconstruction by liquid nitrogen-treated autograft has more merit than artificial joint reconstruction The case of bone and soft tissue tumor required to resection of bone The case agreement is obtained in writing

Exclusion criteria

Exclusion criteria: The case that autograft is impossible for destruction of bone The case that has serious complication (including heart disease, kidney disease, respiratory disease, hematological disease and diabetes mellitus) The case that has uncontrollable infectious disease WBC<2000/ul, Hb<7.0 g/dl, Plt.<50000/ul The case that has difficulty in anesthesia

Design outcomes

Primary

Measure	Time frame
complication the period required for bone union functional outcome	—

Countries

Japan

Contacts

Public ContactTaketsugu Fujibuchi

Ehime University Graduate School of Medicine Bone and Joint Surgery

buchi@m.ehime-u.ac.jp+81-89-960-5343

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026